To be considered clinically relevant, a biomarker must have a high DA; [32] that is, it must have high sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) ...

Sepsis is a common and serious complication in intensive care unit patients. An important factor in optimizing survival rates in septic patients is the ability to start treatment early in the course ...

Sepsis is the body’s overwhelming and life-threatening response to infection, which may rapidly lead to tissue damage, organ failure and death. In the United States alone, sepsis is attributed to more ...

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...

Sepsis is a life-threatening condition caused by organ dysfunction resulting from the body's dysregulated response to infection. Annually, sepsis affects more than 31 million people worldwide, with a ...

Sepsis accounts for around a third of global deaths, with an estimated 166 million cases and 21·4 million all-cause sepsis-related deaths according to a recent study from the Global Sepsis ...

For critically ill patients on antibiotics for suspected sepsis, monitoring one biomarker safely shortened the course of these medications in the ADAPT-Sepsis randomized trial. Daily assessment of ...

Scientists from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago and colleagues identified several proteins from the umbilical cord blood of preterm ...

A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified five proteins in umbilical cord blood that could signal early-onset sepsis in preterm ...